跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MB-1
首页
药物
MB-1
MB-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
MB-1 analogs and uses thereof
申请人: AGROTERRA BIOTECH INC
优先权: 2002
US
MB-1 analogs and uses thereof
申请人: AGROTERRA BIOTECH INC
优先权: 2003
US
In vitro method for determining the stability of compositions comprising soluble Fc gamma receptor(s)
申请人: SUPPREMOL GMBH
优先权: 2013
US
Activated methylene blue bonding medicine as well as preparation method and application thereof
申请人: UNIV HEBEI TECHNOLOGY
优先权: 2024
CN
Activated near-infrared fluorescent probe based on methylene blue as well as preparation method and application of activated near-infrared fluorescent probe
申请人: AFFILIATED HOSPITAL OF ZUNYI MEDICAL UNIV
优先权: 2024
CN
Construction and application of MDA-MB-231 cell strain with estrogen activity
申请人: SHANGHAI JAHWA UNITED CO LTD
优先权: 2021
CN
Photo-curable reparative material for dental use
申请人: TOKUYAMA CORP
优先权: 2000
US
2 件公开
Application of siRNA in improving sensitivity of triple negative breast cancer cell line MDA-MB-468 to tamoxifen
申请人: INSTITUTE OF ADVANCED TECH HEILONGJIANG ACADEMY OF SCIENCES
优先权: 2024
CN
药物
反馈